High Tech Pharm Co. Ltd Net Asset Quality Index
High Tech Pharm Co. Ltd net asset quality index. High Tech Pharm Co. Ltd (106190) has a Net Asset Quality Index of 91.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩139.56 Billion minus total liabilities of ₩12.57 Billion yields net assets of ₩126.99 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 106190 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of High Tech Pharm Co. Ltd (2014–2024)
Net asset quality index of High Tech Pharm Co. Ltd from 2014 to 2024. This chart shows how High Tech Pharm Co. Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 91.0%, representing net assets of ₩126.99 Billion against total assets of ₩139.56 Billion KRW. See 106190 total equity for net asset value and shareholders' equity analysis.
High Tech Pharm Co. Ltd Net Asset Quality Index by Year (2014–2024)
High Tech Pharm Co. Ltd net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for High Tech Pharm Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 106190 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.5% | ₩119.74 Billion | ₩140.09 Billion | ₩20.35 Billion | ▲ +6.3 pp |
| 2023 | 79.2% | ₩106.99 Billion | ₩135.06 Billion | ₩28.06 Billion | ▲ +3.6 pp |
| 2022 | 75.6% | ₩99.94 Billion | ₩132.20 Billion | ₩32.26 Billion | ▼ -0.8 pp |
| 2021 | 76.4% | ₩93.88 Billion | ₩122.94 Billion | ₩29.05 Billion | ▲ +2.3 pp |
| 2020 | 74.1% | ₩95.14 Billion | ₩128.45 Billion | ₩33.30 Billion | ▼ -0.8 pp |
| 2019 | 74.8% | ₩98.58 Billion | ₩131.73 Billion | ₩33.14 Billion | ▼ -2.9 pp |
| 2018 | 77.7% | ₩103.35 Billion | ₩133.00 Billion | ₩29.65 Billion | ▼ -8.1 pp |
| 2017 | 85.8% | ₩102.19 Billion | ₩119.10 Billion | ₩16.90 Billion | ▲ +0.3 pp |
| 2016 | 85.5% | ₩101.18 Billion | ₩118.31 Billion | ₩17.13 Billion | ▼ -1.7 pp |
| 2015 | 87.2% | ₩97.20 Billion | ₩111.43 Billion | ₩14.23 Billion | ▲ +0.9 pp |
| 2014 | 86.4% | ₩92.06 Billion | ₩106.60 Billion | ₩14.53 Billion | — |